[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[$asbp](/topic/$asbp)

### Sentiment: XXX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$asbp/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$asbp/time-series/sentiment.tsv)  
**Current Value**: XXX%  
**Daily Average**: XX%  
**1 Week**: XXX% +25%  
**1 Month**: XXX% no change  
**1-Year High**: XXX% on 2025-05-15  
**1-Year Low**: XX% on 2025-09-23  

**Most Supportive Themes**
- **FDA Roadmap and Product Milestones:** (45%) Positive sentiment surrounds Aspire Biopharma's (ASBP) announcement of its FDA submission roadmap and key milestones.
- **Trading and Profit Opportunities:** (30%) Many social media posts highlight successful trading strategies and profit-making opportunities related to ASBP.
- **Positive News and Breakthroughs:** (15%) News of clinical trial results and potential breakthroughs are generating positive sentiment.
  
**Most Critical Themes**
- **High Risk and Volatility:** (10%)  Some posts caution about the high-risk nature of ASBP, emphasizing its micro-cap status and potential for volatility.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %  |
| ------- | -------- | -   | ------- | -   | -------- | -  |
| TikTok  | X        | X%  | XX      | XX% | X        | X% |
| X       | XXX      | XX% | XXX     | XX% | X        | X% |
| YouTube | X        | X%  | X       | X%  | X        | X% |
|         |          |     |         |     |          |    |
| Total   | XXX      | XX% | XXX     | XX% | X        | X% |